58 signals · bluesky, h1b_lca, newsapi +2 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Moderate stress signals detected across available public data.
Elevated risk signals — operational or reputational pressure patterns observed.
Signal data from 2 sources places Genentech in the Biotech space at moderate workforce stress signals with elevated risk indicators.
Signals for Genentech were collected from 2 sources. Aggregate signal sentiment appears mixed or neutral. The stress score stands at 52/100 with a risk score of 85/100. Signal coverage is sufficient to support a preliminary assessment.
Damon Wayans Partners With Genentech to Raise Awareness for Diabetic Macular Edema geneonline.com
DualityBio and Genentech partner on next-generation ADCs in deal worth over $1 billion biospectrumasia.com
Biotech subsidiary of Roche focused on cancer.
Based on 58 signals across 5 sources · snapshot 18 Sept 2026
Strong — enough signals from diverse sources to trust this score.
Overall community sentiment for Genentech is mixed based on public signals as of 18 Sept 2026.
Based on 58 signals across 5 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
What this means
Moderate internal stress paired with elevated risk signals — conditions bear watching.
AI-generated from public signals — may be incomplete. Based on 4 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
Genentech cuts more than 100 jobs after nearly 500 layoffs last year People Matters Global